Clinical Oncology Next Generation Sequencing (NGS) Market Size, Status and Forecast 2019-2025
NGS allows the testing of all types of variants including single-nucleotide variations, insertions, deletions, exon duplications, gene copy number changes and translocations.
The key factor contributing to the growth of the NGS market is the improved understanding of the genetic markers of virulence and resistance.
In 2018, the global Clinical Oncology Next Generation Sequencing (NGS) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
Download FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-clinical-oncology-next-generation-sequencing-2019-2025-284
This report focuses on the global Clinical Oncology Next Generation Sequencing (NGS) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Clinical Oncology Next Generation Sequencing (NGS) development in United States, Europe and China.
The key players covered in this study
- Illumina
- Roche
- Agilent Technologies
- Knome
- Genomatix Software
- GATC Biotech
- Oxford Nanopore Technologies
- Macrogen
- Life Technologies
- DNASTAR
- Exosome Diagnostics
- Biomatters
- CLC Bio
- BGI
- Qiagen
- Perkin Elmer
- Pacific Bioscience
- Partek
- GnuBIO
- Foundation Medicine
- Paradigm
- Caris Life Sciences
- Myriad Genetics
Market segment by Type, the product can be split into
- NGS Pre-Sequencing
- Sequencing
- NGS Data Analysis
- Primary, Secondary & Tertiary Data Analysis
Market segment by Application, split into
- Academic & Clinical Research
- Hospitals & Clinics
- Pharma & Biotech Entities
Market segment by Regions/Countries, this report covers
- United States
- Europe
- China
- Japan
- Southeast Asia
- India
- Central & South America
The study objectives of this report are:
- To analyze global Clinical Oncology Next Generation Sequencing (NGS) status, future forecast, growth opportunity, key market and key players.
- To present the Clinical Oncology Next Generation Sequencing (NGS) development in United States, Europe and China.
- To strategically profile the key players and comprehensively analyze their development plan and strategies.
- To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Clinical Oncology Next Generation Sequencing (NGS) are as follows:
- History Year: 2014-2018
- Base Year: 2018
- Estimated Year: 2019
- Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Get the Complete Report & TOC @ https://www.grandresearchstore.com/life-sciences/global-clinical-oncology-next-generation-sequencing-2019-2025-284
Table of content
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Size Growth Rate by Type (2014-2025)
1.4.2 NGS Pre-Sequencing
1.4.3 Sequencing
1.4.4 NGS Data Analysis
1.4.5 Primary, Secondary & Tertiary Data Analysis
1.5 Market by Application
1.5.1 Global Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application (2014-2025)
1.5.2 Academic & Clinical Research
1.5.3 Hospitals & Clinics
1.5.4 Pharma & Biotech Entities
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Clinical Oncology Next Generation Sequencing (NGS) Market Size
2.2 Clinical Oncology Next Generation Sequencing (NGS) Growth Trends by Regions
2.2.1 Clinical Oncology Next Generation Sequencing (NGS) Market Size by Regions (2014-2025)
2.2.2 Clinical Oncology Next Generation Sequencing (NGS) Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Clinical Oncology Next Generation Sequencing (NGS) Market Size by Manufacturers
3.1.1 Global Clinical Oncology Next Generation Sequencing (NGS) Revenue by Manufacturers (2014-2019)
3.1.2 Global Clin
CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170 / +91 8087042414
Email: [email protected]
Follow Us On linkedin :- https://www.linkedin.com/company/grand-research-store/